UCD ‘Biomaker Lab’ helps scientists, engineers explore solutions – Davis Enterprise
Davis Enterprise |
UCD ‘Biomaker Lab’ helps scientists, engineers explore solutions
Davis Enterprise It has facilitated various student design projects ranging from new chemical face peels to bio-based glues to novel blood separation devices, and catalyzed the formation of two new project-based courses, one in synthetic biology and one in protein … |
Myeloma Research News |
Autolus Advances New Myeloma CAR T-cell Therapy in Clinical Trial
Myeloma Research News Autolus has successfully completed dosing the first group of patients in a Phase 1/2 trial of AUTO2 — a CAR T-cell therapy that targets two factors that drive disease in patients with relapsed or refractory multiple myeloma. Researchers believe that … |
GeekWire |
Seattle Children’s licenses gene-editing therapy to Casebia Therapeutics and will partner on further research
GeekWire The tech is based on work by Dr. David Rawlings, who leads Seattle Children’s Center for Immunity and Immunotherapies, and Dr. Andrew Scharenberg, who co-led the Program in Cell and Gene Therapy before joining Casebia as its chief scientific officer. |
ABP LIVE |
Intravenous Umbilical Cord Stem Cell Tx Assessed in HFrEF Patients
Monthly Prescribing Reference (registration) HealthDay News — Intravenous infusion of umbilical cord-derived mesenchymal stem cells (UC-MSCs) is safe and efficacious for patients with heart failure and reduced ejection fraction (HFrEF), according to a study published online September 26 in … Umbilical Cord-Derived Stem Cells Could Help Those with Heart FailureTechnology Networks Can Babies Help Heart Patients?Philly.com |
PEOPLE.com |
California Grandmother Needs Live-Saving Stem–Cell Transplant from Sister in Vietnam But the US Won’t Grant Her Visa
PEOPLE.com A 60-year-old grandmother in Garden Grove, California, is fighting for her life after her sister, who is a donor match and lives in Vietnam, was denied a temporary visa to travel to the U.S. for a stem–cell transplant. Helen Huynh, a U.S. citizen who … |
|
Immunotherapy Firm’s Technology Demonstrates ‘Potential Use in Treating Cancers and Bacterial Infections’
Streetwise Reports (registration) The trial of Inovio’s dMAb therapeutic against prostate-specific membrane antigen, the results of which were published in Cancer Immunology, Immunotherapy, showed “the construct produced monoclonal antibodies that controlled growth of human prostate … |